Beth Snyder Bulik

Here's what to watch, now that the Trump administration has set in motion new rules that would require list prices in drug advertising.

Lilly launched a new metastatic breast cancer push, in partnership with actress Mira Sorvino and "Good Morning America," with a televised yoga class.

The FDA OPDP slapped a warning letter on Mannkind for failing to mention Afrezza's risks.

GlaxoSmithKline's new Theraflu rollout? Single-use plastic pods that fit into Keurig coffee makers, hitting shelves this month supported by an ad effort.

FCB Health is looking to humanize data, formalizing that vision into its own distinct next generation big data agency named Solve(d).

Pharma might have thought it could fend off the Trump administration's bid to get drug prices into consumer advertising, but it was wrong.

With three quarters of pharma TV ad spending down and one to go, national media buys are tracking ahead of 2017, with brands doling out $2.81 billion.

Novo Nordisk is firing up its first innovation challenge to scout out tech solutions in diabetes.

The number of open innovation challenges in pharma grows by the day. But what’s driving them? That’s what Luminary Labs wanted to know.

While most pharma companies use data to make marketing decisions, one healthcare agency data veteran says its often used only at the end of campaigns.